News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Almirall presente en JP Morgan 2025
Almirall at the JPMorgan Conference - entering a new era of sustained growth
Healthcare
"2025 is a turning point for Almirall as we are entering an era of sustained double-digit growth of…
Entrevista Francisco Fernández-Avilés – Catedrático de Medicina Cardiovascular de la UCM y Co-fundador de Corify Care
Francisco Fernández-Avilés: "The development of imaging techniques in cardiology helps significantly in decision-making and in the planning of surgical or catheter-based interventions"
Healthcare · Access to innovation
Interview Francisco Fernández-Avilés – Professor of Cardiovascular Medicine at the UCM and Co-…
Muestras de laboratorio
Spain, the EU leader in 2024 in advanced therapy research, with a growing prominence of biotechnological medicines
Healthcare · Advanced therapies
Out of the 930 studies authorized by the AEMPS last year, a total of 52 focused on advanced therapy…
Mujer con gripe
Surveillance and diagnosis of influenza and other seasonal respiratory viruses
Healthcare
Although respiratory diseases are generally not severe, they cause thousands of hospitalizations…
Imagen de un cerebro relacionada con la investigación del Alzhéimer en España
BCN HEALTH publishes a study assessing the epidemiological situation and cost of Alzheimer's disease in Spain
Healthcare
The medical costs of Alzheimer's disease in hospital care increased during the study period, with…
Médico atendiendo a un paciente en una consulta
ORYZON announces first patient dosed in NCI-sponsored iadademstat in combination with venetoclax and azacitidine clinical trial in first line acute myeloid leukemia
Healthcare · Innovative drugs
Study conducted under the CRADA agreement between NCI and Oryzon.
Guillermo Rodriguez Lázaro, Director Científico de Grupo AIA
#NewAseBioMember | “AseBio is a key player in the growth of biotechnology in Spain”
Corporate
Meet Grupo AIA, our new member. We spoke with Guillermo Rodriguez Lázaro, Chief…
sede oryzon
ORYZON to provide corporate progress updates at several events in January-February
Corporate
Among these, the following stand out 8º Sachs Annual Neuroscience Innovation Forum, 14º Annual…
Laboratorio de Viva in Vitro
Key Trends in Sepsis for 2025
Healthcare · Personalized medicine · Advanced therapies
In Spain, the incidence of sepsis is 212 cases per 100,000 inhabitants per year, with a mortality…